Ahren Innovation Capital

Ahren Innovation Capital is a deep tech and deep science investment firm established in 2017. The firm focuses on supporting transformational companies at the intersection of deep technology and deep science, aiming to create or penetrate massive markets. Ahren believes in taking considered risks that deliver superior rewards, capturing a generational opportunity to provide smart capital to deep technology pioneers. The firm partners with exceptional founders and teams at all stages, from pre-seed to pre-IPO, offering both patient and active capital to empower them to achieve the unimaginable.

The firm's investment strategy encompasses four broad domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Ahren's approach is characterized by a genuine partnership between the creators of deep technology and deep science and commercially active, long-term capital. This unique methodology enables the firm to identify and nurture exceptional talent globally while accelerating the development of transformative enterprises. Ahren's portfolio includes companies such as AI21 Labs, Graphcore, Zapata Computing, ZOE, Phaidra, Heirloom Carbon, and Bicycle Therapeutics, among others.

With assets under management exceeding $800 million, Ahren has established itself as a significant player in the deep tech investment landscape. The firm maintains a strategic international presence with team members in Cambridge (UK), London, and Boston, facilitating cross-border collaboration and market expansion for portfolio companies. Ahren's unique positioning at the intersection of scientific excellence and commercial expertise has made it a preferred partner for ambitious founders working at the frontiers of technology, bridging the gap between breakthrough scientific innovation and commercial application to catalyze the development of companies addressing some of humanity's most significant challenges.